Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39292
Title: | SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study | Authors: | Frahm, Niklas Fneish, Firas Ellenberger, David Haas, Judith Loebermann, Micha PARCIAK, Tina Peters, Melanie Poehlau, Dieter Rodgers, Jeff Roeper, Anna-Lena Schilling, Sarah Stahmann, Alexander Temmes, Herbert Zettl, Uwe K. Middleton, Rodden M. |
Issue Date: | 2022 | Publisher: | ELSEVIER | Source: | LANCET REGIONAL HEALTH-EUROPE, 22 (Art N° 100502) | Abstract: | Background Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aimed at analysing vaccination reactions (VRs) and MS deterioration following SARS-CoV-2 vaccinations in German and United Kingdom (UK) PwMS, especially regarding gender-specific differences. Methods The German Multiple Sderosis Society and the UK MS Registry acquired health data via an online system following the first (X-1) and second SARS-CoV-2 vaccination (X-2), respectively: sociodemographic and clinical data, vaccines used, VRs, MS deterioration (worsened or new MS symptoms, Germany only) and relapses (Germany only). The frequencies of VRs and MS deterioration were analysed stratified by gender. Findings Following X-1 (X-2), 2346 (1835) German PwMS and 3796 (683) UK PwMS participated in the study. The most frequent vaccination scheme was two-dose tozinameran for Germany (77.1%, 1424/1847) and two-dose AZD1222 for the UK (61.3%, 419/683). The most common VRs were fatigue, headache and pain (at the injection site) and occurred more often in women compared with men. German PwMS reported VRs more frequently after X-2 vs. X-1 (65.4% [1201/1835] vs. 61.2% [1435/2346]), while for UK patients it was the opposite (X-1 vs. X-2 : 48.7% [1849/3796] vs. 30.0% [205/683]). MS deterioration occurred in 19.0% (445/2346) of the German PwMS without resulting in gender-specific differences. Fatigue and gait impairment were the most frequent deteriorated MS symptoms. Interpretation Female PwMS reported experiencing VRs more often than men. Longitudinal data are needed to enable valid statements regarding long-term MS deterioration and long-lasting VRs. Copyright (C) 2022 MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Project Development gGmbH). Published by Elsevier Ltd. | Notes: | Frahm, N (corresponding author), MS Res & Project Dev gGmbH, Krausenstr 50, D-30171 Hannover, Germany. frahm@msregister.de |
Keywords: | SARS-CoV-2;COVID-19;Vaccination;Vaccination reaction;Multiple sclerosis;Gender;Adverse events | Document URI: | http://hdl.handle.net/1942/39292 | ISSN: | 2666-7762 | DOI: | 10.1016/j.lanepe.2022.100502 | ISI #: | 000898656600003 | Rights: | 2022 MS Forschungs- und Projektentwicklungs-gGmbH (MS Research and Project Development gGmbH). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/) | Category: | A1 | Type: | Journal Contribution | Validations: | vabb 2024 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom_ Gender-specific results from a longitudinal observational study.pdf | Published version | 2.21 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
17
checked on Oct 6, 2024
Page view(s)
42
checked on Aug 6, 2023
Download(s)
14
checked on Aug 6, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.